Herpes zoster in inflammatory rheumatic diseases

Herpes zoster is a viral disease that commonly occurs after a prolonged period of latency due to reactivation of an initial varicella zoster infection. The disease mainly affects older adults and those with impaired immune systems. In the acute phase, individuals experience dermatome-linked pain and papulovesicular rash. The primary complication is excruciating postherpetic neuralgia, which can last several months to years. For precautionary purposes, an inactivated vaccine is available. This vaccine is recommended by the German Standing Committee on Vaccination (STIKO) for individuals with an increased risk profile starting at 50 years of age and as a routine vaccination for individuals aged 60 and older.